Learning to Align Molecules and Proteins: A Geometry-Aware Approach to Binding Affinity
Accurate prediction of drug-target binding affinity can accelerate drug discovery by prioritizing promising compounds before costly wet-lab screening. While deep learning has advanced this task, most models fuse ligand and protein representations via simple concatenation and lack explicit geometric regularization, resulting in poor generalization across chemical space and time. We introduce FIRM-DTI, a lightweight framework that conditions molecular embeddings on protein embeddings through a feature-wise linear modulation (FiLM) layer and enforces metric structure with a triplet loss. An RBF regression head operating on embedding distances yields smooth, interpretable affinity predictions. Despite its modest size, FIRM-DTI achieves state-of-the-art performance on the Therapeutics Data Commons DTI-DG benchmark, as demonstrated by an extensive ablation study and out-of-domain evaluation. Our results underscore the value of conditioning and metric learning for robust drug-target affinity prediction.
Code (0)
등록된 구현이 없습니다.
Tasks
Metric LearningDrug DiscoverySimilar Papers 제목 키워드 기반
GraphVF: Controllable Protein-Specific 3D Molecule Generation with Variational Flow
Designing molecules that bind to specific target proteins is a fundamental task in drug discovery. Recent models leverage geometric constraints to generate ligand molecules that bind cohesively with specific protein pock…
3D geometry3D Molecule GenerationDrug DiscoveryGenerating 3D Molecules for Target Protein Binding
A fundamental problem in drug discovery is to design molecules that bind to specific proteins. To tackle this problem using machine learning methods, here we propose a novel and effective framework, known as GraphBP, to …
Drug DiscoveryGraph Neural NetworkPrior-Guided Flow Matching for Target-Aware Molecule Design with Learnable Atom Number
Structure-based drug design (SBDD), aiming to generate 3D molecules with high binding affinity toward target proteins, is a vital approach in novel drug discovery. Although recent generative models have shown great poten…
Drug DiscoveryFragment and Geometry Aware Tokenization of Molecules for Structure-Based Drug Design Using Language Models
Structure-based drug design (SBDD) is crucial for developing specific and effective therapeutics against protein targets but remains challenging due to complex protein-ligand interactions and vast chemical space. Althoug…
Drug DesignDesign of Ligand-Binding Proteins with Atomic Flow Matching
Designing novel proteins that bind to small molecules is a long-standing challenge in computational biology, with applications in developing catalysts, biosensors, and more. Current computational methods rely on the assu…